Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 35M | 0 |
| Cost of revenue | 45.2M | 57.5M | 0 | 11.2M |
| Gross profit | -45.2M | -57.5M | 35M | -11.2M |
| Operating expense | ||||
| Research & development | 166.1M | 72.5M | 82.2M | 82.2M |
| Selling general and admin | 18.9M | 19.3M | 18.1M | 17.4M |
| Other operating expenses | -892K | -865K | -691K | -602K |
| Operating income | -229.3M | -148.4M | -64.6M | -110.1M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 22.1M | 13.5M | 28.0M | 25.1M |
| Pretax income | -207.3M | -134.9M | -36.6M | -85.1M |
| Tax provision | 1.3M | 1.1M | 700K | 876K |
| Net income | -208.5M | -136.0M | -37.3M | -85.9M |
| Basic EPS | -2.4 | -1.6 | -0.4 | -1.0 |
| Diluted EPS | -2.4 | -1.6 | -0.4 | -1.0 |
| Basic average shares | 87.1M | 85.9M | 85.5M | 85.2M |
| Diluted average shares | 87.1M | 85.9M | 85.5M | 85.2M |
| EBITDA | -224.7M | -143.7M | -59.7M | -105.4M |
| Net income from continuing op. | -208.5M | -136.0M | -37.3M | -85.9M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |